Investigation of the Phenylalkylamine Binding Site in hKv1.3 (H399T), a Mutant with a Reduced C-Type Inactivated State

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Pharmacology

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.105.012401PMID 16000530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.

  2004cited by this paper
• K+ Channel Expression during B Cell Differentiation: Implications for Immunomodulation and Autoimmunity1

  2004cited by this paper
• Di-substituted cyclohexyl derivatives bind to two identical sites with positive cooperativity on the voltage-gated potassium channel, K(v)1.3.

  2003cited by this paper
• SWISS-MODEL: an automated protein homology-modeling server

  2003cited by this paper
• Potassium channels as therapeutic targets for autoimmune disorders.

  2003cited by this paper
• Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel.

  2003cited by this paper
• Crystal structure and mechanism of a calcium-gated potassium channel

  2002cited by this paper
• The open pore conformation of potassium channels

  2002cited by this paper
• Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties.

  2002cited by this paper
• Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis.

  2001cited by this paper
• Binding of Correolide to the Kv1.3 Potassium Channel: Characterization of the Binding Domain by Site-Directed Mutagenesis†

  2001cited by this paper
• Block of the lymphocyte K+ channel mKv1.3 by the phenylalkylamine verapamil: Kinetic aspects of block and disruption of accumulation of block by a single point mutation

  2000influential reference
• Structural Differences of Bacterial and Mammalian K+Channels*

  2000cited by this paper
• Contribution of the selectivity filter to inactivation in potassium channels.

  1999cited by this paper
• The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998influential reference
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• Molecular Determinants of High Affinity Phenylalkylamine Block of l-type Calcium Channels in Transmembrane Segment IIIS6 and the Pore Region of the α1Subunit*

  1997cited by this paper
• Dynamic rearrangement of the outer mouth of a K+ channel during gating.

  1996cited by this paper
• Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines.

  1996cited by this paper
• Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.

  1996cited by this paper
• The IVS6 segment of the L‐type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.

  1996cited by this paper
• Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3.

  1996cited by this paper
• Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4

  1996influential reference
• Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles.

  1995influential reference
• Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor.

  1995cited by this paper
• Protein Modeling by E-mail

  1995cited by this paper
• C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism.

  1995cited by this paper
• Mechanism of K+ channel block by verapamil and related compounds in rat alveolar epithelial cells

  1995cited by this paper
• Molecular Determinants of High Affinity Phenylalkylamine Block of L-type Calcium Channels (*)

  1995cited by this paper
• An engineered cysteine in the external mouth of a K+ channel allows inactivation to be modulated by metal binding.

  1994cited by this paper
• Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels.

  1991cited by this paper
• Interaction between tetraethylammonium and amino acid residues in the pore of cloned voltage-dependent potassium channels.

  1991cited by this paper
• Automated docking of substrates to proteins by simulated annealing

  1990influential reference
• TEA prevents inactivation while blocking open K+ channels in human T lymphocytes.

  1989cited by this paper
• Voltage-gated potassium channels are required for human T lymphocyte activation

  1984cited by this paper
• Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?

  1984cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper

• Identification of WP1066, an inhibitor of JAK2 and STAT3, as a KV1.3 potassium channel blocker

  2021cites this paper
• Discovery of KV1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges

  2021cites this paper
• Kinetic Aspects of Verapamil Binding (On-Rate) on Wild-Type and Six hKv1.3 Mutant Channels

  2017cites this paper
• State‐dependent blocking mechanism of Kv1.3 channels by the antimycobacterial drug clofazimine

  2015influential citation
• Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells

  2014influential citation
• Effekt von MTS-Reagenzien auf humane spannungsabhängige hKv1.3 Wildtyp, hKv1.3_V417C mutierte und hKv1.3_V417C-H399T mutierte Kaliumkanäle: Implikationen für den C-Typ inaktivierten Zustand

  2013cites this paper
• Structural changes of the outer and inner vestibule of hKv1.3 channels during C type inactivation

  2012cites this paper
• Verapamil‐ and state‐dependent effect of 2‐aminoethylmethanethiosulphonate (MTSEA) on hKv1.3 channels

  2012cites this paper
• Effect of verapamil on the action of methanethiosulfonate reagents on human voltage‐gated Kv1.3 channels: implications for the C‐type inactivated state

  2011cites this paper
• A Novel Current Pathway Parallel to the Central Pore in a Mutant Voltage-gated Potassium Channel*

  2011cites this paper
• Why Does the Inner-Helix Mutation A413C Double the Stoichiometry of Kv1.3 Channel Block by Emopamil but Not by Verapamil?

  2011cites this paper
• Overlapping Binding Sites of Structurally Different Antiarrhythmics Flecainide and Propafenone in the Subunit Interface of Potassium Channel Kv2.1*

  2010cites this paper
• Potassium Channel Block by a Tripartite Complex of Two Cationophilic Ligands and a Potassium Ion

  2010cites this paper
• The functional network of ion channels in T lymphocytes

  2009cites this paper
• Effect of K+ and Rb+ on the action of verapamil on a voltage‐gated K+ channel, hKv1.3: implications for a second open state?

  2009cites this paper
• Molecular Modeling of Benzothiazepine Binding in the L-type Calcium Channel*

  2008cites this paper
• K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

  2008cites this paper
• Functional characterization of KCNJ2 mutations associated with Andersen-Tawil syndrome and atrial

  2007cites this paper
• Lehmann-Horn Functional characterization of KCNJ 2 mutations associated with Andersen-Tawil syndrome and atrial tachycardia

  2007cites this paper
• RESEARCH PAPER State-dependent blocking mechanism of K v 1.3 channels by the antimycobacterial drug clofazimine

  year unknowninfluential citation